FDA Strengthens Warning For Type 2 Diabetes Meds
The U.S. Food and Drug Administration on Thursday strengthened the warning for Janssen Pharmaceuticals Inc.'s Type 2 diabetes drug Invokana, or canagliflozin, and related product Invokamet that contains canagliflozin to include...To view the full article, register now.
Already a subscriber? Click here to view full article